logo
logo

Newomics Closes $7.9 Million Series B Financing to Accelerate Growth

Dec 01, 2020•over 4 years ago

Amount Raised

$7 Million

Round Type

series b

Berkeley

Description

Newomics Inc., a biotechnology company developing and commercializing mass spectrometry solutions for molecular detection applications, today announced the closing of their $7.9 million Series B financing, led by MSA Capital. Joining the round are new investor LDV Partners, and existing Series A investors, including the Berkeley Catalyst Fund and the Photon Fund.

Company Information

Company

Newomics

Location

Berkeley, California, United States

About

Newomics Inc. is dedicated to creating and commercializing innovative (New) and integrative (Omics) platforms and solutions for precision medicine. The company’s products deliver the robustness of microflow LC and the sensitivity of nanospray ionization MS. The plug-and-play MnESI platform (MnESI source + M3 emitter) is currently interfaced to diverse MS instruments and can be ordered at www.newomics.com.

Related People